Klingenstein Fields & CO LP Gilead Sciences, Inc. Transaction History
Klingenstein Fields & CO LP
- $2.49 Billion
- Q2 2025
A detailed history of Klingenstein Fields & CO LP transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Klingenstein Fields & CO LP holds 9,039 shares of GILD stock, worth $1.1 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
9,039
Previous 9,064
0.28%
Holding current value
$1.1 Million
Previous $1.02 Million
1.28%
% of portfolio
0.04%
Previous 0.04%
Shares
28 transactions
Others Institutions Holding GILD
# of Institutions
2,352Shares Held
1.02BCall Options Held
12.1MPut Options Held
9.13M-
Black Rock Inc. New York, NY121MShares$14.7 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA119MShares$14.6 Billion0.22% of portfolio
-
State Street Corp Boston, MA59.2MShares$7.22 Billion0.25% of portfolio
-
Capital World Investors Los Angeles, CA46.3MShares$5.65 Billion0.78% of portfolio
-
Wellington Management Group LLP Boston, MA37.5MShares$4.58 Billion0.79% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $153B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...